RhumbLine Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-71,723
Closed -$4.99M 4198
2024
Q3
$4.99M Sell
71,723
-6,678
-9% -$458K ﹤0.01% 1429
2024
Q2
$5.27M Buy
78,401
+9,446
+14% +$636K 0.01% 1369
2024
Q1
$4.76M Sell
68,955
-582
-0.8% -$39.3K ﹤0.01% 1444
2023
Q4
$4.33M Sell
69,537
-45
-0.1% -$2.52K ﹤0.01% 1506
2023
Q3
$3.9M Buy
69,582
+1,026
+1% +$57.7K ﹤0.01% 1495
2023
Q2
$3.46M Buy
68,556
+1,828
+3% +$97.3K ﹤0.01% 1600
2023
Q1
$3.64M Buy
66,728
+1,273
+2% +$74.4K ﹤0.01% 1491
2022
Q4
$4.09M Buy
65,455
+4,551
+7% +$302K 0.01% 1391
2022
Q3
$4.29M Buy
60,904
+5,974
+11% +$412K 0.01% 1327
2022
Q2
$3.11M Buy
54,930
+7,083
+15% +$388K ﹤0.01% 1519
2022
Q1
$3M Buy
47,847
+2,265
+5% +$122K ﹤0.01% 1601
2021
Q4
$2.55M Sell
45,582
-111
-0.2% -$6.78K ﹤0.01% 1745
2021
Q3
$2.97M Buy
45,693
+3,687
+9% +$252K ﹤0.01% 1666
2021
Q2
$2.66M Buy
42,006
+8,436
+25% +$498K ﹤0.01% 1803
2021
Q1
$2.01M Sell
33,570
-3,926
-10% -$213K ﹤0.01% 1913
2020
Q4
$1.87M Buy
37,496
+634
+2% +$29.8K ﹤0.01% 1879
2020
Q3
$1.88M Sell
36,862
-5,688
-13% -$237K ﹤0.01% 1716
2020
Q2
$1.49M Buy
42,550
+21,998
+107% +$758K ﹤0.01% 1875
2020
Q1
$522K Buy
20,552
+2,994
+17% +$89K ﹤0.01% 2147
2019
Q4
$487K Buy
17,558
+339
+2% +$8.09K ﹤0.01% 2372
2019
Q3
$464K Buy
17,219
+98
+0.6% +$3.41K ﹤0.01% 2352
2019
Q2
$701K Buy
+17,121
New +$481K ﹤0.01% 2223

Other funds holding AXNX

RhumbLine Advisers's AXNX Position: Q4 2024 in Review

RhumbLine Advisers sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 71,723 shares — an estimated $4.99M sold.

RhumbLine Advisers first reported a position in AXNX in Q2 2019 and held it in 22 quarters. The position peaked at $5.27M in Q2 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • RhumbLine Advisers reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 71,723 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $4.99M.
  • RhumbLine Advisers first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 22 quarters.
  • RhumbLine Advisers's Axonics, Inc. Common Stock position peaked at $5.27M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.